Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1632 1654 1656 1678
This examiner grants 66% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17929124 | METHODS AND COMPOSITIONS FOR MODULATING A GENOME | Non-Final OA | FLAGSHIP PIONEERING INNOVATIONS VI, LLC |
| 18267024 | METHODS AND MATERIALS FOR TREATING PROSTATE CANCER | Non-Final OA | Mayo Foundation for Medical Education and Research |
| 17725407 | METHODS AND COMPOSITIONS FOR THE POSITIVE SELECTION OF PROTEIN DESTABILIZERS | Non-Final OA | Dana-Farber Cancer Institute, Inc. |
| 17905583 | IN VIVO mRNA DISPLAY: LARGE-SCALE PROTEOMICS BY NEXT GENERATION SEQUENCING | Final Rejection | The Trustees of Columbia University in the City of New York |
| 17786168 | GENOME EDITING USING REVERSE TRANSCRIPTASE ENABLED AND FULLY ACTIVE CRISPR COMPLEXES | Final Rejection | MASSACHUSETTS INSTITUTE OF TECHNOLOGY |
| 17997453 | ALBUMIN DRUG CONJUGATES AND USE THEREOF FOR THE TREATMENT OF CANCER | Final Rejection | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM |
| 18137921 | INTRINSICALLY DISORDERED PROTEINS FOR EXTRACTION OF NUCLEIC ACIDS | Non-Final OA | UNM Rainforest Innovations |
| 18037934 | THERMOTOLERANT PROTEIN GLUTAMINASE | Final Rejection | AMANO ENZYME INC. |
| 18773428 | METHODS OF EDITING DNA METHYLATION | Non-Final OA | Whitehead Institute for Biomedical Research |
| 17276619 | DEPLETING UNWANTED RNA SPECIES | Final Rejection | QIAGEN Sciences, LLC |
| 17587643 | SYSTEMS AND METHODS FOR ASSESSING A TARGET MOLECULE | Non-Final OA | AXBIO INC. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy